Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease

Front Pharmacol. 2013 Mar 22:4:31. doi: 10.3389/fphar.2013.00031. eCollection 2013.
No abstract available